Neonatal Alloimmune Thrombocytopenia – NAIT Survey Study request.January 26, 2014Our Summer 2013 newsletter is now out!July 18, 2013 on July 30, 2013 DateJuly 30, 2013 Tromplate® the medicine being developed by the PROFNAIT Project, which has already been granted Orphan Drug Status in the EU has just been granted Orphan Drug Status by the FDA in the US!!!! http://www.profnait.eu/en-parents/donate-plasma/ Share Related postsJune 4, 2024May 2024 – Doctor Thijs W de Vos receives prize for the best dissertation 2023-24 within the field, at the NVB-TRIP Symposium!Read moreMay 14, 2024Care Design New York – Member Spotlight – Meet Chris!!!Read moreApril 25, 202410 April 2024-FNAIT Collaboration Agreement between Momenta Pharmaceuticals, Inc., a Johnson & Johnson Company, and Rallybio IPA, LLCRead more
